Please use this identifier to cite or link to this item:
Title: Efficacy of pravastatin in combination with captopril in hypertensive patients.
Austin Authors: O'Callaghan, Christopher J ;Krum, Henry;Conway, Elizabeth L;Lam, W;Skiba, M A;Howes, L G;Louis, William J 
Affiliation: Hypertension Services, Austin Hospital, Melbourne, VIC.
Issue Date: 20-Feb-1995
Publication information: Medical Journal of Australia; 162(4): 206-8
Abstract: To determine the efficacy of pravastatin in the treatment of primary hypercholesterolaemia in patients being treated with captopril for hypertension.A double-blind parallel group study comparing 12 weeks of pravastatin therapy (20-40 mg/day) with placebo.25 patients (age, 37-73 years) with mild-to-moderate hypertension and hypercholesterolaemia (total cholesterol level, 5.5-8.8 mmol/L).Pravastatin reduced total cholesterol levels by 22% (from 7.1 +/- 0.29 [SEM] to 5.5 +/- 0.25 mmol/L; P < 0.001) and low-density-lipoprotein cholesterol levels by 32% (from 5.0 +/- 0.32 to 3.4 +/- 0.28 mmol/L; P < 0.001) in four weeks and these levels were maintained for the 12 weeks of therapy. Pre-pravastatin values returned three weeks after stopping therapy. Levels of total cholesterol, cholesterol fractions and triglycerides remained constant or deteriorated in the placebo group. Pravastatin therapy was well tolerated. An integrated coronary risk score showed a 40% reduction in risk.This study indicates that pravastatin (combined with captopril) is an effective cholesterol-lowering drug, but that treatment needs to be maintained.
Gov't Doc #: 7877544
Journal: Medical Journal of Australia
Type: Journal Article
Subjects: Adult
Analysis of Variance
Captopril.therapeutic use
Double-Blind Method
Drug Therapy, Combination
Hypercholesterolemia.blood.complications.drug therapy
Hypertension.blood.complications.drug therapy
Middle Aged
Pravastatin.therapeutic use
Treatment Outcome
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Jul 21, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.